Portfolio company news

All Group media enquiries should be directed to
Vanessa Maydon, Corporate Affairs Director.

Cinven Partners LLP
Warwick Court
Paternoster Square
London EC4M 7AG


Tel: +44 (0)20 7661 3325
Mob: +44 (0)7802 961 902
Email: Vanessa Maydon

Press releases

7 August 2015

Cinven completes acquisition of Labco

Cinven has today completed the acquisition of Labco, one of the largest European operators of medical diagnostic laboratories, for an enterprise value of €1.2bn.

Cinven's healthcare team identified Labco as an attractive investment opportunity on the basis of its strong market fundamentals; diversification (by geography, payor and business model); medical leadership in specialist areas such as anatomical pathology, genetic testing and nuclear medicine; strong historic financial performance; and the opportunity to further consolidate the highly fragmented European diagnostics laboratory market.

Following the acquisition of Labco, headquartered in France, Cinven announced the acquisition of synlab, a German headquartered provider of human veterinary laboratory services and environmental analysis across Europe, in June 2015. The combination of synlab with Labco creates the new European champion in the diagnostics industry.

Labco represents the twelfth investment from Cinven's Fifth Fund.